Ambalal Sarabhai (500009)
Slow GrowerFairStock Score: 56/100 — STEADY
Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹68.47 |
| Market Cap | ₹524.71 Cr |
| P/E Ratio | 11.35 |
| ROCE | 9.12% |
| ROE | 7.49% |
| Dividend Yield | 0% |
| Profit Growth | 93.72% |
| Debt/Equity | — |
| Sales Growth | 13.12% |
| 52-Week Range | ₹23.12 — ₹68.47 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹6.1 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At ₹68.47, Ambalal Sarabhai looks like a growth story at first glance. A trailing P/E of 11.35 and 93.72% profit growth are eye-catching, and the Piotroski score of 7/9 suggests the business is improving. But I have to stop and reconcile the numbers before paying a rupee. The book value is only ₹6.10, yet I'm asked to pay ₹68.47 — over 11 times book. A company earning a 7.49% ROE on that book value would generate about 46 paise per share; at ₹68.47, that's a P/E of nearly 150, not 11.35. Something is off. Either the earnings used for the P/E are not sustainable, or the ROE figure is stale. When the balance sheet and income statement tell different stories, I move on.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer